U.S. biotech companies Alnylam, Dicerna settle trade secrets case

BOSTON (Reuters) - Dicerna Pharmaceuticals Inc on Friday said that it will pay $15 million plus stock to Alnylam Pharmaceuticals Inc to resolve a lawsuit claiming it stole trade secrets about gene-silencing technology used to develop drug treatments.

from Reuters: Technology News https://ift.tt/2vuiMbL